Apogenix GmbH: Clinical Trials

1 trial sponsored by Apogenix GmbH, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Apogenix GmbH: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
APG101 in Glioblastoma
APG101, Blood drawing - Glioblastoma Multiforme
Phase 2CompletedApogenix GmbH842009-12-012015-06-16

Conditions studied

Glioblastoma (1)

Interventions

APG101 (1)  ·  Blood Specimen Collection (1)  ·  Recombinant Fusion Proteins (1)

Countries

Austria (1)  ·  Germany (1)

Top investigators

Wolfgang Wick, MD (1)